Navigation Links
News from the Latest Issue of Molecular Medicine Kicking The Habit - It's In The Genes
Date:6/29/2009

Scientists at the National Institute on Drug Abuse (VIDA) working in collaboration with colleagues at Vector Tobacco, Inc. and Duke University Medical School have identified genes that may help predict which people will have a better chance at kicking the tobacco habit.

Manhasset, NY (Vocus) June 29, 2009 -- Scientists at the National Institute on Drug Abuse (VIDA) working in collaboration with colleagues at Vector Tobacco, Inc. and Duke University Medical School have identified genes that may help predict which people will have a better chance at kicking the tobacco habit. NIDA's Tomas Drgon, PhD, and colleagues conducted a genome-wide association study that identified patterns that may determine quitting success rates. If replicated, genetic testing could be used to tailor smoking cessation programs to individuals.

In another study, a team of Swedish investigators examined insulin signaling in fat cells of lean individuals before, during and after a month-long high fat diet. During the study, the volunteers gained an average of 10 percent of their body weight and 19 percent total body fat. While they remained lean, they did develop moderate systemic insulin resistance. Insulin resistance has become an enormous public health problem that paves the way to type 2 diabetes and other medical conditions. It is the first study to measure the effects of a short-term high fat diet, and it shows that the assault of such a diet is already causing damage to the body's ability to regulate insulin. This study suggests a path for how diabetes may develop in otherwise healthy individuals and provides further evidence that a high-calorie, high-fat diet is a significant risk factor for type 2 diabetes.

Also, in a possible future breakthrough for personalized medicine, Dr. H. Shaw Warren of Massachusetts General Hospital and colleagues from research centers nationwide took advantage of genomic screening methods to assess gene expression from trauma patient blood samples. They developed a scoring method that assigns a single value based on genome wide expression patterns termed the difference from reference score, or DFR. The authors found that DFR scoring improves upon existing methodologies for predicting outcomes in trauma patients. High throughput approaches such as DFR scoring could improve the quality and efficacy of trauma patient care.

You can view all of the articles in the July-August issue by visiting the journal's Web site at www.molmed.org.

Molecular Medicine is published by The Feinstein Institute for Molecular Research. The peer-reviewed journal strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. The journal, a bimonthly publication, serves as a forum through which scientists and researchers can communicate recent discoveries to a multi-disciplinary, international audience interested in understanding and curing disease.

To listen to the latest podcast on these studies visit www.molmed.org/podcast.html.

Veronica J Davis, communications editor, 516-562-2670

###

Read the full story at http://www.prweb.com/releases/smoking/insulin/prweb2584204.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
2. Scientists, physicians present latest findings in personalized cancer treatment and prevention
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Health psychologists discuss latest research findings
5. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
6. PA Governor Rendell Announces Latest Nominations and Appointments
7. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
8. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
9. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
10. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
11. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
News from the Latest Issue of Molecular Medicine Kicking The Habit - It's In The Genes
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: